In patients with ovarian clear cell carcinoma, the expression of the CSC maker aldehyde dehydrogenase-1 (ALDH1) was strongly correlated with an advanced clinical stage and reduced progression free survival [161]. This evidence concerns the gene ALDH1A1 and ovarian clear cell cancer.